Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Accuracy and Errors in Hypothesis Testing01:13

Accuracy and Errors in Hypothesis Testing

642
Hypothesis testing is a fundamental statistical tool that begins with the assumption that the null hypothesis H0 is true. During this process, two types of errors can occur: Type I and Type II. A Type I error refers to the incorrect rejection of a true null hypothesis, while a Type II error involves the failure to reject a false null hypothesis.
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
642
Decision Making: P-value Method01:09

Decision Making: P-value Method

7.1K
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim  is also stated. These statements can act as null and alternative hypotheses:  a null hypothesis would be a neutral statement while the alternative hypothesis can...
7.1K
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

467
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
467
P-value01:10

P-value

9.1K
P-value is one of the most crucial concepts in statistics.
P-value stands for the probability value.  P-value is the probability that, if the null hypothesis is true, the results from another randomly selected sample will be as extreme or more extreme as the results obtained from the given sample.
A large P-value calculated from the data indicates to  not reject the null hypothesis. But a higher P-value does not mean that the null hypothesis is true. The smaller the P-value, the more...
9.1K
Errors In Hypothesis Tests01:14

Errors In Hypothesis Tests

6.1K
When performing a hypothesis test, there are four possible outcomes depending on the actual truth (or falseness) of the null hypothesis and the decision to reject or not.
6.1K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

674
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
674

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular Profiling and Matched Targeted Therapy for Patients With Advanced Melanoma: Results From Part 1 of the MatchMEL Study.

JCO precision oncology·2026
Same author

Real-world evaluation of the use of melanoma risk prediction tools by clinicians in Australia: a mixed-methods study.

The British journal of dermatology·2026
Same author

Effectiveness of a stepped-care model to address fear of cancer recurrence in patients with early-stage melanoma: results at 6- and 12-month follow-up.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2025
Same author

In situ and localized primary invasive pregnancy-associated melanoma: Maternal and perinatal outcomes.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma.

Journal for immunotherapy of cancer·2025
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Mar 3, 2026

Tactile Semiautomatic Passive-Finger Angle Stimulator TSPAS
04:40

Tactile Semiautomatic Passive-Finger Angle Stimulator TSPAS

Published on: July 30, 2020

3.3K

Accurate p-values for adaptive designs with binary endpoints.

Stephane Heritier1, Chris J Lloyd2, Serigne N Lô3,4

  • 1School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

Statistics in Medicine
|May 5, 2017
PubMed
Summary
This summary is machine-generated.

This study introduces novel methods to accurately control error rates in adaptive clinical trials. The new approach ensures reliable results, especially for complex trial designs with varying sample sizes.

Keywords:
Simesadaptive designbootstrap p-valuecombination testfamilywise error ratesecond-order test

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K

Related Experiment Videos

Last Updated: Mar 3, 2026

Tactile Semiautomatic Passive-Finger Angle Stimulator TSPAS
04:40

Tactile Semiautomatic Passive-Finger Angle Stimulator TSPAS

Published on: July 30, 2020

3.3K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Methods

Background:

  • Confirmatory adaptive designs require strict control of the family-wise error rate for regulatory acceptance.
  • Existing methods for adaptive trials, while theoretically sound, can exhibit poor performance and inflated Type I error rates, particularly with unbalanced sample sizes or small to moderate sample sizes.

Purpose of the Study:

  • To address the issue of inflated Type I error rates in adaptive clinical trials.
  • To propose and validate novel statistical methods for robust error rate control in adaptive designs.

Main Methods:

  • Utilizing second-order accurate p-values, specifically bootstrap p-values, to feed adaptive tests.
  • Implementing an adjusted Simes procedure to mitigate conservatism in testing intersection hypotheses.

Main Results:

  • The proposed methods successfully preserve the overall error rate at or below the nominal level across various scenarios.
  • Unlike standard methods, the new approach demonstrates robustness irrespective of baseline success rates, stagewise sample sizes, or allocation ratios.

Conclusions:

  • The novel approach using bootstrap p-values and an adjusted Simes procedure offers a reliable solution for error rate control in adaptive clinical trials.
  • This methodology enhances the validity and regulatory acceptance of adaptive trial designs, particularly those with complex characteristics.